News

Filter

Current filters:

Epoprostenol sodium

1 to 9 of 30 results

Actelion acquires new thermo-stable PAH drug

02-03-2009

Swiss drugmaker Actelion is to acquire an improved, thermostable formulation of intravenous pulmonary…

Epoprostenol sodiumFlolanGeneraMedix

FDA clears Teva's Flolan ANDA

05-05-2008

Israel-headquartered Teva Pharmaceutical Industries says that the US Food and Drug Administration has…

Amino AcidsEpoprostenol sodiumFlolanGlaxoSmithKlineGSKInjectionPhysostigmine SalicylateTeva Pharmaceutical Industries

Gilead pays $2.5B, a 50% premium, for Mycogen to get heart drug candidates

09-10-2006

Gilead Sciences has announced plans to acquire fellow USA-based Myogen in order to gain control of the…

bosentanEpoprostenol sodiumFlolanGilead SciencesGiliad SciencesGlaxoSmithKlineGSKNovartisTracleer

GlaxoSmithKline and Myogen sign ambrisentan licensing deal and Flolan distribution agreement

13-03-2006

UK pharmaceutical major GlaxoSmithKline has announced a two-part collaboration with Denver, USA-based…

Epoprostenol sodiumFlolanGlaxoSmithKlineGSK

United Thera: EU MRP ends for Remodulin

22-08-2005

United Therapeutics Corp of the USA says that, following the first European Union approval in France…

Amino AcidsEpoprostenol sodiumFlolanGlaxoSmithKlineGSKInjectionPhysostigmine SalicylateRemodulinTreprostinil Sodium

Actelion

19-08-2002

Swiss biopharmaceutical company Actelion has reported turnover of 26.9million Swiss francs ($18.2 million)…

bosentanEpoprostenol sodiumFlolanGlaxoSmithKlineGSKRemodulinTracleerTreprostinil Sodium

1 to 9 of 30 results

COMPANY SPOTLIGHT

Menarini

Back to top